CA2066313CCA 2066313CA2066313ACA2066313CCA 2066313 CCA2066313 CCA 2066313CCA 2066313 CA2066313 CA 2066313CA 2066313 ACA2066313 ACA 2066313ACA 2066313 CCA2066313 CCA 2066313C
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
compositions
methyl
glioma
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/781,020external-prioritypatent/US5260291A/en
Application filed by Cancer Research Campaign Technology LtdfiledCriticalCancer Research Campaign Technology Ltd
Publication of CA2066313A1publicationCriticalpatent/CA2066313A1/fr
Application grantedgrantedCritical
Publication of CA2066313CpublicationCriticalpatent/CA2066313C/fr
Pochodne terpenoidowe (Sarcodictyiny) do stosowania jako środki przeciwnowotworowe i zwiększające łączenie się tubuliny, ich zastosowanie do wytwarzania leków oraz zawierające je kompozycje farmaceutyczne